Pneumo 23 - instructions for use, analogs, testimonials and release forms (injections in ampoules for injections or inoculations) of a vaccine for the treatment and prevention of pneumococcal infection in adults, children and during pregnancy. Composition

In this article, you can get acquainted with the instructions for the use of the drug vaccine Pneumo 23. There are reviews of visitors to the site - consumers of this medication, as well as opinions of specialists in the use of Pnevmo 23 in their practice. A big request is to actively add their feedback on the drug: the medicine helped or did not help get rid of the disease, which were observed complications and side effects, possibly not declared by the manufacturer in the annotation. Analogues Pnevmo 23 in the presence of existing structural analogues.Use of vaccination for the treatment and prevention of pneumococcal infection in adults, children, as well as during pregnancy and lactation. Composition of the preparation.

Pneumo 23 highly purified multivalent vaccine. It is a purified polysaccharide Streptococcus pneumoniae (streptococcus) 23 serotypes: 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, 33F. It causes the formation of immunity to the indicated serotypes of Streptococcus pneumoniae. Immunity is acquired 10-15 days after a single vaccination and lasts for at least 5 years. After the introduction of this vaccine seroconversion is observed, at least, in 90% of vaccinated persons.

Composition

Polysaccharides of Streptococcus pneumoniae (23 serotypes, each serotype of 25 μg) + auxiliary substances.

Indications

• prevention of infections of the pneumococcal etiology, especially of respiratory tract infections, in persons at risk, beginning at the age of 2 years.

Forms of release

Solution for intramuscular and subcutaneous injection (injections in ampoules or syringes for injections).

Instructions for use and technique of vaccination

The vaccine is administered subcutaneously or intramuscularly. Primary vaccination is carried out with a single dose of this vaccine once. Revaccination is carried out every five years.The interval between revaccinations can be reduced in individuals from high-risk groups or patients who receive immunosuppressants.

Side effect

• weakness;
• slight increase in body temperature;
• chills;
• headache (duration - not more than 24 hours);
• local reactions - redness, mild soreness or compaction at the injection site, after vaccination.

Contraindications

• a marked reaction to the previous administration of the vaccine;
• anti-pneumococcal vaccination or pneumococcal disease (caused by one of the vaccine-containing serotypes) for a period of up to 5 years before the planned vaccination with this vaccine.

Application in pregnancy and lactation

Despite the fact that information about adverse effects on the fetus when using the Pnevmo vaccine 23 in pregnancy is not available, vaccination of pregnant women from risk groups is not recommended.

Use in children

It shows the use of the vaccine in children at risk from 2 years of age.

special instructions

Vaccination is especially indicated for patients with sickle-cell anemia, as well as persons with asplenia who have undergone splenectomy or before splenectomy.

When revaccination, performed earlier than the prescribed time, severe local reactions may occur.

In connection with the possibility of developing serious adverse reactions and complications (such as the Arthus phenomenon) during vaccination, contraindications should be strictly observed, and the benefits of vaccination should be assessed. At the same time, it is necessary to take into account that the determination of the effectiveness of the anti-pneumococcal vaccination was carried out only in persons at risk.

Immunosuppressive therapy can reduce or completely suppress the immune response to the administration of this vaccine.

Drug Interactions

Not noted.

Analogues of the drug Pneumo 23

Structural analogs for the active substance:

• Pneumovax 23 (Vaccine pneumococcal, polyvalent);
• Prevenar (pneumococcal polysaccharide conjugated adsorbed vaccine);
• Prevenar 13 (vaccine pneumococcal polysaccharide conjugated adsorbed, thirteen-valent);
• Sinflorix (Vaccine 10-valent pneumococcal polysaccharide, conjugated with D-protein atypable Haemophilus influenza, tetanus and diphtheria toxoid, adsorbed).

Similar medicines:

Other medicines: